Who will assess your device/ATMP combination in the EU? New paper explains all
This article was originally published in RAJ Devices
Executive Summary
How do manufacturers appoint a rapporteur and assessment team responsible for assessing their marketing approval applications in the European Union for advanced therapy medicinal products, including ones that are ATMP/device combinations?